Heart Diseases — Evaluation of the LVivo Image Quality Scoring (IQS)
Citation(s)
Blanco P, Volpicelli G Common pitfalls in point-of-care ultrasound: a practical guide for emergency and critical care physicians. Crit Ultrasound J. 2016 Dec;8(1):15. Epub 2016 Oct 26. Review.
Dall T et al. The Complexities of Physician Supply and Demand: Projections From 2019 to 2034. Association Of American Medical Collage, 2021.
Dixon, W J., Massey, F.J. Introduction to Statistical Analysis. 4th Edition McGraw-Hill, 1983. pp. 105-107
Goldman, L et al. Echocardiography. Elsevier, Inc, 2020. pp. 253-260
Kumar V There is No Substitute for Human Intelligence. Indian J Crit Care Med. 2021 May;25(5):486-488. doi: 10.5005/jp-journals-10071-23832.
Liu B R et al. Emergency Ultrasound Standard Reporting Guidelines. ACEP, 2018. pp. 2-44.
Nagata Y, Kado Y, Onoue T, Otani K, Nakazono A, Otsuji Y, Takeuchi M Impact of image quality on reliability of the measurements of left ventricular systolic function and global longitudinal strain in 2D echocardiography. Echo Res Pract. 2018 Mar;5(1):27-39. doi: 10.1530/ERP-17-0047. Epub 2018 Feb 5.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.